Predicting Abrocitinib Efficacy at Week 12 Based on Clinical Response at Week 4: A Post Hoc Analysis of Four Randomized Studies in Moderate-to-Severe Atopic Dermatitis.

Autor: Armstrong, April W.1 (AUTHOR), Alexis, Andrew F.2 (AUTHOR), Blauvelt, Andrew3 (AUTHOR), Silverberg, Jonathan I.4 (AUTHOR), Feeney, Claire5 (AUTHOR) Claire.Feeney@pfizer.com, Levenberg, Mark6 (AUTHOR), Chan, Gary7 (AUTHOR), Zhang, Fan7 (AUTHOR), Fostvedt, Luke8 (AUTHOR)
Zdroj: Dermatology & Therapy. Jul2024, Vol. 14 Issue 7, p1849-1861. 13p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje